Related Experiment Video
Updated: Aug 28, 2025

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Mortality audit of COVID-19 infection among children
Raman Sharma1, Ashish Agarwal1, Ankit Ranjan2
1Division of Paediatric Emergency & Critical Care, Advanced Paediatrics Centre, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Insights
In children with SARS-CoV-2 infection, all-cause mortality was 9.9%, while COVID-19 specific mortality was 1.9%. Most deaths were linked to underlying comorbidities, not solely the virus.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Critical Care Medicine
Background:
- Severe COVID-19 is uncommon in children, leading to limited data on mortality causes.
- Understanding mortality in pediatric SARS-CoV-2 infections is crucial for accurate risk assessment.
Purpose of the Study:
- To determine all-cause mortality and COVID-19 specific mortality in children admitted to a pediatric COVID facility.
- To identify the causes of death in non-survivor children infected with SARS-CoV-2.
Main Methods:
- Retrospective analysis of clinical and epidemiological data of SARS-CoV-2 positive children (0-12 years).
- Study conducted at a tertiary care COVID hospital in North India from April 2020 to June 2021.
- Focused on non-survivors to determine causes of death.
Main Results:
- 475 children admitted, 47 died (9.9% all-cause mortality).
- COVID-19 specific mortality was 1.9% (9 deaths).
- Comorbidities (prematurity, congenital heart disease) were present in 74.5%; common causes of death included septic shock, COVID pneumonia, and neonatal illnesses.
Conclusions:
- A low disease-specific mortality from COVID-19 was observed in children.
- Mortality in pediatric COVID-19 cases can be overestimated if all-cause and disease-specific deaths are not differentiated.
- Standardized recording of causes of death in pediatric SARS-CoV-2 infections is essential.
Background & Objectives:
As severe COVID-19 and mortality are not common in children, there is a scarcity of data regarding the cause of mortality in children infected with SARS-CoV-2. This study was aimed to describe the all-cause mortality and COVID-19 death (disease-specific mortality) in children with SARS-CoV-2 infection admitted to a paediatric COVID facility in a tertiary care centre.
Methods:
Data with respect to clinical, epidemiological profile and causes of death in non-survivors (0-12 yr old) of SARS-CoV-2 infection admitted to a dedicated tertiary care COVID hospital in north India between April 2020 and June 2021 were retrieved and analyzed retrospectively.
Results:
A total of 475 SARS-CoV-2-positive children were admitted during the study period, of whom 47 died [18 neonates, 14 post-neonatal infants and 15 children (1-12 yr of age)]. The all-cause mortality and COVID-19 death (disease-specific mortality) were 9.9 per cent (47 of 475) and 1.9 per cent (9 of 475), respectively. Underlying comorbidities were present in 35 (74.5%) children, the most common being prematurity and perinatal complications (n=11, 24%) followed by congenital heart disease (n=6, 13%). The common causes of death included septic shock in 10 (21%), COVID pneumonia/severe acute respiratory distress syndrome in nine (19%), neonatal illnesses in eight (17%), primary central nervous system disease in seven (15%) and congenital heart disease with complication in six (13%) children.
Interpretation & Conclusions:
Our results showed a high prevalence of underlying comorbidities and a low COVID-19 death (disease-specific mortality). Our findings highlight that mortality due to COVID-19 can be overestimated if COVID-19 death and all-cause mortality in children infected with SARS-CoV-2 are not separated. Standardized recording of cause of death in children with SARS-CoV-2 infection is important.
Related Concept Videos
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Life Tables
Cancer Survival Analysis
Censoring Survival Data
Pneumonia III: Complications and Assessment

